The DOI matches its Crossref record; 204 of the 204 references it cites were found in a registry or an index.
Oxidative stress in psychiatric disorders: evidence base and therapeutic implications
Open accessAbstract
Oxidative stress has been implicated in the pathogenesis of diverse disease states, and may be a common pathogenic mechanism underlying many major psychiatric disorders, as the brain has comparatively greater vulnerability to oxidative damage. This review aims to examine the current evidence for the role of oxidative stress in psychiatric disorders, and its academic and clinical implications. A literature search was conducted using the Medline, Pubmed, PsycINFO, CINAHL PLUS, BIOSIS Preview, and Cochrane databases, with a time-frame extending to September 2007. The broadest data for oxidative stress mechanisms have been derived from studies conducted in schizophrenia, where evidence is available from different areas of oxidative research, including oxidative marker assays, psychopharmacology studies, and clinical trials of antioxidants. For bipolar disorder and depression, a solid foundation for oxidative stress hypotheses has been provided by biochemical, genetic, pharmacological, preclinical therapeutic studies and one clinical trial. Oxidative pathophysiology in anxiety disorders is strongly supported by animal models, and also by human biochemical data. Pilot studies have suggested efficacy of N-acetylcysteine in cocaine dependence, while early evidence is accumulating for oxidative mechanisms in autism and attention deficit hyperactivity disorder. In conclusion, multi-dimensional data support the role of oxidative stress in diverse psychiatric disorders. These data not only suggest that oxidative mechanisms may form unifying common pathogenic pathways in psychiatric disorders, but also introduce new targets for the development of therapeutic interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This model is consistent with the idea that stress related to psychopathology is associated with physiological and cellular alterations related to telomere length, such as elevated oxidative stress or inflammation.25”
From Telomere Length and Psychopathology: Specificity and Direction of Effects Within the Bucharest Early Intervention Project (2020) · cites this paper as [25]
Experimental — accuracy not yet measuredIn the citing paper
“Oxidative stress in psychiatric disorders could result from the overproduction of ROS, impairments in Keap1-Nrf2 signalling, or both due to causes related to psychological stress, physiological impairments, inflammation, and genetic polymorphisms of antioxidant enzymes that are beyond the scope of this review [126,127].”
From Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease (2022) · cites this paper as [126]
In the citing paper
“Importantly, antioxidants have shown promising therapeutic benefits in the treatment of psychiatric disorders and are subject to further investigation [126,127,140].”
From Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease (2022) · cites this paper as [126]
In the citing paper
“bipolar disorder (BD) [10–14]”
From Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches (2016) · cites this paper as [13]
In the citing paper
“Coming back to NAC, which is a precursor of glutathione, it has been shown that it can significantly improve the standard therapy, as a double-blind randomized placebo-controlled clinical study performed by Ng et al. in 2008 demonstrated [13].”
From Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches (2016) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Free radicals and antioxidants in normal physiological functions and human disease
Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.07.001 · Cited by 14,269
Journal of Clinical Psychiatry
(2018) · Journal of Clinical Psychiatry · doi:10.5505/kpd · Cited by 13,703
Oxidants, oxidative stress and the biology of ageing
Finkel, T., & Holbrook, N. J. (2000) · Nature · doi:10.1038/35041687 · Cited by 9,413
Nitric Oxide and Peroxynitrite in Health and Disease
Pacher, P., Beckman, J. S., & Liaudet, L. (2007) · Physiological Reviews · doi:10.1152/physrev.00029.2006 · Cited by 6,390
Oxidative stress: oxidants and antioxidants
Sies, H. (1997) · Experimental Physiology · doi:10.1113/expphysiol.1997.sp004024 · Cited by 4,577
Neurodegenerative diseases and oxidative stress
Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683 · cited 1×
“In a similar vein, oxidation biology is emerging as a promising avenue of investigation, and has been actively pursued in other areas of medicine (Barnham et al., 2004; Mehta et al., 2006; Tsukahara, 2007).”
BackgroundSelf-citationOxidative stress and neurodegeneration: where are we now?
Halliwell, B. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03907.x · Cited by 2,614
Vitamin E, antioxidant and nothing more
Traber, M. G., & Atkinson, J. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.03.024 · Cited by 1,547
Untreated Depression and Hippocampal Volume Loss
Sheline, Y. I., Gado, M. H., & Kraemer, H. C. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.8.1516 · Cited by 1,180
Oxidative stress: the paradox of aerobic life
Davies, K. J. A. (1995) · Biochemical Society Symposia · doi:10.1042/bss0610001 · Cited by 1,150
Research works printed but not linked: 9
- Li, 2006, Journal of Zhejiang University. Science B, 7, 1981
- 10.1002/(SICI)1099-0801(199809/10)12:53.0.CO;2-# · DOI
- Frey, 2006, Journal of Psychiatry and Neurosciences, 31, 326
- Zhou, 2007, Biological Psychiatry, none, none
- Zhou, 1999, Chinese Medical Journal, 112, 1093
- Berk, 2007, Bipolar Disorders, 9, 3
- Ben Othmen, 2007, Progress in Neuropsychopharmacology and Biological Psychiatry, none, none
- Young, 2007, Journal of Psychiatry and Neurosciences, 32, 160
- Baker, 2007, Neuropsychopharmacology, none, none
Cited by
Sorted by citations
Items 201–300 of 1,000
Short overview on metabolomic approach and redox changes in psychiatric disorders
Erjavec, G. N., Konjevod, M., Perković, M. N., Štrac, D. Š., Tudor, L., Barbas, C., Grune, T., Žarković, N., & Pivac, N. (2017) · Redox Biology · doi:10.1016/j.redox.2017.09.002 · Cited by 82
Jorgensen, A., Krogh, J., Miskowiak, K., Bolwig, T. G., Kessing, L. V., Fink-Jensen, A., Nordentoft, M., Henriksen, T., Weimann, A., Poulsen, H. E., et al. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.02.011 · Cited by 74
Mandal, P. K., Gaur, S., Roy, R. G., Samkaria, A., Ingole, R., & Goel, A. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00420 · Cited by 78
Prohan, M., Amani, R., Nematpour, S., Jomehzadeh, N., & Haghighizadeh, M. H. (2014) · Redox Report · doi:10.1179/1351000214y.0000000085 · Cited by 77
Rojas, P., Serrano-García, N., Medina-Campos, O. N., Pedraza-Chaverri, J., Ögren, S. O., & Rojas, C. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.05.007 · Cited by 76
Nierenberg, A. A., Kansky, C., Brennan, B. P., Shelton, R. C., Perlis, R. H., & Iosifescu, D. V. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412449303 · Cited by 78
Pathobiological targets of depression
Chopra, K., Kumar, B., & Kuhad, A. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.553603 · Cited by 76
Magalhães, P. V. D. S., Jansen, K., Pinheiro, R. T., Colpo, G. D., da Motta, L. L., Klamt, F., da Silva, R. A., & Kapczinski, F. P. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001532 · Cited by 75
Verlaet, A. A. J., Breynaert, A., Ceulemans, B., Bruyne, T. D., Fransén, E., Pieters, L. A. C., Savelkoul, H. F. J., & Hermans, N. (2018) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-018-1239-4 · Cited by 78
Taurine modulates the stress response in zebrafish
Mezzomo, N. J., Fontana, B. D., Müller, T. E., Duarte, T., de Quadros, V. A., Canzian, J., Pompermaier, A., Soares, S. M., Koakoski, G., Loro, V. L., et al. (2019) · Hormones and Behavior · doi:10.1016/j.yhbeh.2019.02.006 · Cited by 75
Omega-3 prevents behavior response and brain oxidative damage in the ketamine model of schizophrenia
Zugno, A. I., Chipindo, H. L., Volpato, A. M., Budni, J., Steckert, A. V., de Oliveira, M. B., Heylmann, A. S., Silveira, F. D. R., Mastella, G. A., Maravai, S. G., et al. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.11.049 · Cited by 76
Ben‐Azu, B., Aderibigbe, A. O., Eneni, A.-E. O., Ajayi, A. M., Umukoro, S., & Iwalewa, E. O. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2590-z · Cited by 73
Effects of risperidone and haloperidol on superoxide dismutase and nitric oxide in schizophrenia
Zhang, X., Zhou, D. F., Shen, Y., Zhang, P. Y., Zhang, W. F., Liang, J., Chen, D. C., Xiu, M. H., Kosten, T. A., & Kosten, T. R. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.12.014 · Cited by 74
Casaril, A. M., Domingues, M., Fronza, M. G., Vieira, B. M., Begnini, K. R., Lenardao, E. J., Seixas, F. K., Collares, T. V., Nogueira, C. W., & Savegnago, L. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117711713 · Cited by 75
Nutrient intakes are correlated with overall psychiatric functioning in adults with mood disorders
Davison, K. M., & Kaplan, B. J. (2012) · The Canadian Journal of Psychiatry · doi:10.1177/070674371205700205 · Cited by 73
Tobore, T. O. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112560 · Cited by 73
Yang, Y., Liu, Y., Wang, G., Hei, G., Wang, X., Li, R., Li, L., Wu, R., & Zhao, J. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.01.051 · Cited by 73
Karanikas, E., Daskalakis, N. P., & Agorastos, A. (2021) · Brain Sciences · doi:10.3390/brainsci11060723 · Cited by 78
Malaspina, P., Roullet, J., Pearl, P. L., Ainslie, G. R., Vogel, K. R., & Gibson, K. M. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.06.009 · Cited by 73
Wang, R., Xue, D., Liu, Y., Liu, P., & Chen, H. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15061160 · Cited by 73
Kasote, D. M., Hegde, M. V., & Katyare, S. S. (2013) · BioFactors · doi:10.1002/biof.1093 · Cited by 73
Is there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive Disorder
Young, J. J., Silber, T., Bruno, D., Galatzer‐Levy, I. R., Pomara, N., & Marmar, C. R. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00072 · Cited by 73
Harvey, B. H., Duvenhage, I., Viljoen, F. P., Scheepers, N., Malan, S. F., Wegener, G., Brink, C. B., & Petzer, J. P. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.07.037 · Cited by 70
Oxidative stress and glutathione response in tissue cultures from persons with major depression
Gibson, S. A., Korade, Ž., & Shelton, R. C. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.06.008 · Cited by 71
Galé, C. R., Sayer, A. A., Cooper, C. C., Dennison, E. M., Starr, J. M., Whalley, L. J., Gallacher, J., Ben‐Shlomo, Y., Kuh, D. J., Hardy, R., et al. (2011) · Psychological Medicine · doi:10.1017/s0033291711000195 · Cited by 74
Pharmacology of Olive Biophenols
Obied, H. K., Prenzler, P. D., Omar, S. H., Ismael, R., Servili, M., Esposto, S., Taticchi, A., Selvaggini, R., & Urbani, S. (2012) · Advances in molecular toxicology · doi:10.1016/b978-0-444-59389-4.00006-9 · Cited by 68
Ba, D. M., Gao, X., Al‐Shaar, L., Muscat, J. E., Chinchilli, V. M., Beelman, R. B., & Richie, J. P. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.07.080 · Cited by 70
Chen, C., & Nakagawa, S. (2023) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/171565 · Cited by 77
Manosso, L. M., Neis, V. B., Moretti, M., Daufenbach, J. F., Freitas, A. E., Colla, A. R. D. S., & Rodrigues, A. L. S. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.06.012 · Cited by 69
Phenome-transcriptome correlation unravels anxiety and depression related pathways
Gormanns, P., Mueller, N. S., Ditzen, C., Wolf, S., Holsboer, F., & Turck, C. W. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.12.010 · Cited by 68
Cecerska-Heryć, E., Polikowska, A., Serwin, N., Roszak, M., Grygorcewicz, B., Heryć, R., Michalczyk, A., & Dołęgowska, B. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2021.105269 · Cited by 68
Gu, X., Liu, Q., Deng, F., Wang, X., Lin, H., Guo, X., & Wu, S. (2019) · The British Journal of Psychiatry · doi:10.1192/bjp.2018.295 · Cited by 66
RetractedPatki, G., Solanki, N., Atrooz, F., Ansari, A., Allam, F., Jannise, B., Maturi, J., & Salim, S. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.04.011 · Cited by 71
Godlewska, B. R., Yip, S. W., Near, J., Goodwin, G. M., & Cowen, P. J. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3244-0 · Cited by 67
Madireddy, S., & Madireddy, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031844 · Cited by 76
Spanemberg, L., Caldieraro, M. A., Vares, E. A., de Aguiar, B. W., Kawamoto, S. Y., Parker, G. B., Fleck, M. P. D. A., Kauer‐Sant’Anna, M., & Galvao, E. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s66504 · Cited by 66
DNA Damage in Major Psychiatric Diseases
Raza, M. U., Tufan, T., Wang, Y., Hill, C. P., & Zhu, M. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9621-9 · Cited by 70
Rationale for Dietary Antioxidant Treatment of ADHD
Verlaet, A. A. J., Maasakkers, C. M., Hermans, N., & Savelkoul, H. F. J. (2018) · Nutrients · doi:10.3390/nu10040405 · Cited by 70
Antidepressant mechanism of ketamine: perspective from preclinical studies
Scheuing, L., Chiu, C., Liao, H., & Chuang, D. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00249 · Cited by 66
Machado‐Vieira, R., Pivovarova, N. B., Stanika, R. I., Yuan, P., Wang, Y., Zhou, R., Zarate, C. A., Drevets, W. C., Brantner, C. A., Baum, A. E., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.10.019 · Cited by 65
Parvalbumin interneuron alterations in stress-related mood disorders: A systematic review
Perlman, G., Tanti, A., & Mechawar, N. (2021) · Neurobiology of Stress · doi:10.1016/j.ynstr.2021.100380 · Cited by 71
Singh, D., Rashid, M., Hallan, S. S., Mehra, N. K., Prakash, A. K., & Mishra, N. (2015) · Artificial Cells Nanomedicine and Biotechnology · doi:10.3109/21691401.2014.998824 · Cited by 66
Bulut, M., Selek, S., Bez, Y., Karababa, İ. F., Kaya, M., Güneş, M., Emhan, A., Aksoy, N., & Sır, A. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.03.011 · Cited by 65
Mokoena, M. L., Harvey, B. H., Viljoen, F. P., Ellis, S. M., & Brink, C. B. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3928-8 · Cited by 65
Oxidative stress in children and adolescents with anxiety disorders
Güney, E., Ceylan, M. F., Tektas, A., Alışık, M., Ergin, M., Göker, Z., Dinç, G. Ş., Ozturk, O., Korkmaz, Ş. A., Eker, S., et al. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.11.016 · Cited by 67
Ibi, M., Liu, J., Arakawa, N., Kitaoka, S., Kawaji, A., Matsuda, K., Iwata, K., Matsumoto, M., Katsuyama, M., Zhu, K., et al. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.2988-16.2017 · Cited by 66
Patel, S., Sharma, D., Kalia, K., & Tiwari, V. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.08.025 · Cited by 65
Rabie, A. M., Tantawy, A. S., & Badr, S. M. I. (2016) · American Journal of Organic Chemistry · doi:10.5923/j.ajoc.20160602.02 · Cited by 64
Zeni, A. L. B., Camargo, A., & Dalmagro, A. P. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.02.004 · Cited by 66
Manosso, L. M., Camargo, A., Dafré, A. L., & Rodrigues, A. L. S. (2020) · Nutritional Neuroscience · doi:10.1080/1028415x.2020.1853417 · Cited by 64
Oxidative stress in depressive patients with gastric adenocarcinoma
Wei, Y., Zhou, F., He, D., Bai, J.-R., Ding, H., Wang, X., & Nan, K. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709000091 · Cited by 64
de Oliveira, I. J. L., Souza, V., Motta, V., & Da-Silva, S. L. (2014) · Pakistan Journal of Biological Sciences · doi:10.3923/pjbs.2015.11.18 · Cited by 64
Bipolar Disorder and the Vascular System: Mechanisms and New Prevention Opportunities
Goldstein, B. I. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.10.006 · Cited by 65
Magliaro, B. C., & Saldanha, C. J. (2009) · Brain Research · doi:10.1016/j.brainres.2009.05.063 · Cited by 63
Antidepressant-like effects of N-acetyl-L-cysteine in rats
Ferreira, F. R., Biojone, C., Joca, S. R. L., & Guimarães, F. S. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283123c98 · Cited by 63
Djordjevic, J., Djordjevic, A. D., Adžić, M., Mitić, M., Lukić, I., & Radojcic, M. B. (2015) · Brain Research · doi:10.1016/j.brainres.2015.01.010 · Cited by 65
New Therapeutic Targets for Mood Disorders
Machado‐Vieira, R., Salvadore, G., Diazgranados, N., Ibrahim, L. A., Latov, D. R., Wheeler‐Castillo, C., Baumann, J., Henter, I. D., & Zarate, C. A. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.65 · Cited by 64
Casey, J. A., Wilcox, H. C., Hirsch, A. G., Pollak, J., & Schwartz, B. S. (2018) · Scientific Reports · doi:10.1038/s41598-018-29747-2 · Cited by 65
Molecular Hydrogen: an Emerging Therapeutic Medical Gas for Brain Disorders
Wu, C., Zou, P., Feng, S., Zhu, L., Li, F., Liu, T. C., Duan, R., & Yang, L. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03175-w · Cited by 69
Kato, T. A., Monji, A., Yasukawa, K., Mizoguchi, Y., Horikawa, H., Seki, Y., Hashioka, S., Han, Y.-H., Kasai, M., Sonoda, N., et al. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.03.019 · Cited by 63
Choy, K. H. C., Dean, O. M., Berk, M., Bush, A. I., & van den Buuse, M. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.09.035 · Cited by 62
Self-citationCamfield, D., Sarris, J. J., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.02.011 · Cited by 62
Self-citationSteenkamp, L. R., Hough, C. M., Reus, V. I., Jain, F. A., Epel, E. S., James, S. J., Morford, A. E., Mellon, S. H., Wolkowitz, O. M., & Lindqvist, D. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.04.042 · Cited by 62
El‐Naga, R. N., Ahmed, H. I., & Haleem, E. N. A. A. (2014) · NeuroToxicology · doi:10.1016/j.neuro.2014.05.004 · Cited by 61
Rammal, H., Bouayed, J., & Soulimani, R. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.11.001 · Cited by 61
Griñán‐Ferré, C., Palomera‐Ávalos, V., Puigoriol‐Illamola, D., Camins, A., Porquet, D., Plá, V., Aguado, F., & Pallàs, M. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.03.014 · Cited by 60
Camargo, A., Dalmagro, A. P., Rikel, L., da Silva, E. B., da Silva, K. A. B. S., & Zeni, A. L. B. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.07.002 · Cited by 62
A pilot study of cortical glutathione in youth with depression
Freed, R. D., Hollenhorst, C. N., Weiduschat, N., Mao, X., Kang, G., Shungu, D. C., & Gabbay, V. (2017) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2017.10.001 · Cited by 74
Reduced plasma total antioxidant status in first-episode drug-naive patients with schizophrenia
Li, X. F., Zheng, Y. L., Xiu, M. H., Chen, D. C., Kosten, T. R., & Zhang, X. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.03.001 · Cited by 60
Sarris, J., Camfield, D., & Berk, M. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.04.051 · Cited by 59
Self-citationCoccaro, E. F., Lee, R., & Gozal, D. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.01.014 · Cited by 59
Elevated levels of urinary markers of oxidatively generated DNA and RNA damage in bipolar disorder
Munkholm, K., Poulsen, H. E., Kessing, L. V., & Vinberg, M. (2014) · Bipolar Disorders · doi:10.1111/bdi.12245 · Cited by 58
Brain Lipids and Lipid Droplet Dysregulation in Alzheimer’s Disease and Neuropsychiatric Disorders
Zhao, X., Zhang, S., Sanders, A. R., & Duan, J. (2023) · Complex Psychiatry · doi:10.1159/000535131 · Cited by 54
Riveros, M. E., Ávila, A., Schruers, K. R. J., & Ezquer, F. E. (2022) · Antioxidants · doi:10.3390/antiox11030540 · Cited by 60
Sphingolipids in Psychiatric Disorders and Pain Syndromes
Mühle, C., Reichel, M., Gulbins, E., & Kornhuber, J. (2013) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-7091-1511-4_22 · Cited by 58
Wu, Z., Zhang, X., Wang, H., Tang, W., Xia, Y., Zhang, F., Liu, J., Fu, Y., Hu, J., Chen, Y., et al. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.08.018 · Cited by 58
Nail-Biting Stuff? The Effect of N-acetyl Cysteine on Nail-Biting
Berk, M., Jeavons, S., Dean, O. M., Dodd, S., Moss, K., Gama, C. S., & Malhi, G. S. (2009) · CNS Spectrums · doi:10.1017/s1092852900023002 · Cited by 58
Self-citationOudin, A., Åström, D. O., Asplund, P., Steingrímsson, S., Szabó, Z., & Carlsen, H. K. (2018) · Environmental Health · doi:10.1186/s12940-017-0348-8 · Cited by 65
A preliminary investigation on the efficacy of N -acetyl cysteine for mania or hypomania
Vieira da Silva Magalhães, P., Dean, O. M., Bush, A. I., Copolov, D. L., Malhi, G. S., Kohlmann, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., & Berk, M. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413481631 · Cited by 58
Self-citationSalahinejad, A., Attaran, A., Naderi, M., Meuthen, D., Niyogi, S., & Chivers, D. P. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.141633 · Cited by 57
Effect of oxidative stress on TRPM2 and TRPC3 channels in B lymphoblast cells in bipolar disorder
Roedding, A. S., Gao, A. F., Au‐Yeung, W., Scarcelli, T., Li, P. P., & Warsh, J. J. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2012.01003.x · Cited by 57
Sarandöl, A., Sarandöl, E., Açıkgöz, E., Eker, S. S., Akkaya, C., & Dirican, M. (2015) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12333 · Cited by 59
Jindal, A., Mahesh, R., & Bhatt, S. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.01.020 · Cited by 59
Kim, H. K., Andreazza, A. C., Yeung, P., Isaacs-Trepanier, C., & Young, L. T. (2014) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.130155 · Cited by 57
Why Should Psychiatrists and Neuroscientists Worry about Paraoxonase 1?
Moreira, E. G., Boll, K. M., Correia, D. G., Soares, J. F., Rigobello, C., & Maes, M. H. J. (2018) · Current Neuropharmacology · doi:10.2174/1570159x17666181227164947 · Cited by 57
Liu, M.-W., Chen, Q., Towne, S. D. C., Zhang, J., Yu, H.-J., Tang, R., Gasevic, D., Wang, P.-G., & He, Q.-Q. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.10.007 · Cited by 50
Büttiker, P., Weissenberger, S., Esch, T., Anders, M., Raboch, J., Ptáček, R., Kream, R. M., & Stefano, G. B. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1095923 · Cited by 65
Sordi, A. O., Pechansky, F., Kessler, F. H. P., Kapczinski, F. P., Pfaffenseller, B., Gubert, C., de Aguiar, B. W., Narvaez, J. C. D. M., Ornell, F. R., & DIEMEN, L. V. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3542-1 · Cited by 60
Donato, F., de Gomes, M. G., Goes, A. T. R., Seus, N., Alves, D. A. C., Jessé, C. R., & Savegnago, L. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.07.024 · Cited by 56
Increased DNA and RNA damage by oxidation in patients with bipolar I disorder
Jacoby, A. S., Vinberg, M., Poulsen, H. E., Kessing, L. V., & Munkholm, K. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.141 · Cited by 56
Liao, D., Chen, Y., Guo, Y., Wang, C., Liu, N., Gong, Q., Fu, Y., Fu, Y., Cao, L., Yao, D., et al. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s249363 · Cited by 56
Ishimoto, T., & Kato, Y. (2022) · FEBS Letters · doi:10.1002/1873-3468.14271 · Cited by 59
Shen, J., Hao, C., Yuan, S., Chen, W., Tong, T., Chen, Y., Aslam, M. S., Yan, S., Li, J., Zeng, J., et al. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148715 · Cited by 55
Role of melatonin supplementation in neurodegenerative disorders
Polimeni, G. (2014) · Frontiers in bioscience · doi:10.2741/4217 · Cited by 57
Lu, J. L., Wu, D., Hu, B., Zheng, Y., Zhang, Z., & Wang, Y. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00397.x · Cited by 54
Inflammation and schizophrenia
Al-Asmari, A., & Khan, M. W. (2013) · Human & Experimental Toxicology · doi:10.1177/0960327113493305 · Cited by 55
Ali, F. T., El-Azeem, E. M. A., Hamed, M. A., Ali, M. A. M., Abdel-Kader, N. M., & Hassan, E. A. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.01.016 · Cited by 55
Getting a Knack for NAC: N-Acetyl-Cysteine.
Sansone, R. A., & Sansone, L. A. (2011) · PubMed Central · Cited by 54
Neuroinflammatory genes associated with post-traumatic stress disorder
Zass, L. J., Hart, S. A., Seedat, S., Hemmings, S. M. J., & Malan‐Müller, S. (2016) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000143 · Cited by 53
Barbosa, M. L., de Menezes, A. P. M., de Aguiar, R. P. S., Sousa, J. M. D. C. E., Cavalcante, A. A. D. C. M., & Maluf, S. W. (2020) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2020.02.006 · Cited by 56
Metadata
- Authors
- Ng, F., Berk, M., Dean, O., & Bush, A. I.
- Affiliations
- Barwon Health (AU)
- Mental Health Research Institute (AU)
- Venue
- The International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-01-21
- Volume
- 11
- Issue
- 06
- Pages
- 851-76
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- OpenAlex
- W1986211748
- Cited by
- 1,069
- References
- 203
- Citations by year
- 2026: 23 · 2025: 52 · 2024: 49 · 2023: 60 · 2022: 52 · 2021: 81 · 2020: 73 · 2019: 69 · 2018: 74 · 2017: 42 · 2016: 84 · 2015: 71 · 2014: 74 · 2013: 68 · 2012: 50
- FWCI
- 4.26
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The International Journal of Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Deakin Research Online (Deakin University) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- oxidative stress, mental illness, schizophrenia, bipolar disorder, depression, anxiety disorders, cocaine dependence, autism spectrum disorder, attention deficit hyperactivity disorder, antioxidants, N-acetylcysteine, oxidative stress biomarkers, psychopharmacology, common pathogenic mechanisms
- MeSH terms
- Antioxidants, Mental Disorders, Humans, Databases, Bibliographic, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review